california semaglutide Over half a million Californians could lose access to the hugely popular GLP-1 weight loss drugs starting Jan. 1, 2026, after the state government decided to deny some Medi-Cal coverage for the Semaglutide - Koshland Pharm

NAION is caused by a disruption in blood flow to the optic nerve at the back of the eye and typically presents suddenly upon waking and without pain

Read more about affordable online weight-loss clinics

Moreover, a 81.8% of comorbidities remission was observed in particular for OSA [107]

Novo Nordisk/Septerna (May 2025) Novo committed $2.2B to partner with Septerna (US startup) on an oral obesity drug candidate ( [30] )

A possible explanation for such different findings might be linked to the amount of coffee bioactives other than CGA provided with the two different coffee brews

As a licensed nurse providing home-based GLP-1 weight loss care, I help patients every day understand whether they qualify, what BMI really means, and why eligibility goes beyond just a number on a chart